EU Council says it’s time to act for biotech 

Good news from Brussels: the Council of the European Union officially endorsed the EU Biotech Act and life sciences strategy. This marks a united commitment from all EU Member States to make Europe the most attractive place for biotech innovation by 2030. In its conclusions, the Council sends a clear political signal oddly familiar to what hollandbio is calling for: it’s time to act for biotech. It calls for a stronger innovation ecosystem with a business-friendly regulatory framework, coordinated governance and better support for frontrunners. While the final EU Biotech Act still needs to be drafted and negotiated, this endorsement gives the European Commission a strong mandate to move forward. The coming months will be crucial to ensure the strategy delivers real impact — for health, sustainability, and Europe’s global competitiveness.